Broad spectrum antiviral agent niclosamide and its therapeutic potential
The recent outbreak of coronavirus disease 2019 (COVID-19) highlights an urgent need for
therapeutics. Through a series of drug repurposing screening campaigns, niclosamide, an …
therapeutics. Through a series of drug repurposing screening campaigns, niclosamide, an …
Niclosamide for Covid-19: bridging the gap
Aim/purpose Niclosamide (NCL) is an anthelminthic drug, which is widely used to treat
various diseases due to its pleiotropic anti-inflammatory and antiviral activities. NCL …
various diseases due to its pleiotropic anti-inflammatory and antiviral activities. NCL …
Overview of recent strategic advances in medicinal chemistry
G Wu, T Zhao, D Kang, J Zhang, Y Song… - Journal of medicinal …, 2019 - ACS Publications
Introducing novel strategies, concepts, and technologies that speed up drug discovery and
the drug development cycle is of great importance both in the highly competitive …
the drug development cycle is of great importance both in the highly competitive …
Emerging antiviral therapeutics for human adenovirus infection: Recent developments and novel strategies
Human adenoviruses (HAdV) are ubiquitous human pathogens that cause a significant
burden of respiratory, ocular, and gastrointestinal illnesses. Although HAdV infections are …
burden of respiratory, ocular, and gastrointestinal illnesses. Although HAdV infections are …
Oncolytic virotherapy: From bench to bedside
Oncolytic viruses are naturally occurring or genetically engineered viruses that can replicate
preferentially in tumor cells and inhibit tumor growth. These viruses have been considered …
preferentially in tumor cells and inhibit tumor growth. These viruses have been considered …
Niclosamide encapsulated in mesoporous silica and geopolymer: A potential oral formulation for COVID-19
COVID-19 is a rapidly evolving emergency, for which there have been no specific
medication found yet. Therefore, it is necessary to find a solution for this ongoing pandemic …
medication found yet. Therefore, it is necessary to find a solution for this ongoing pandemic …
Expanding the activity spectrum of antiviral agents
Highlights•Broad-spectrum antivirals target≥ 3 viral diseases.•108 safe-in-man broad-
spectrum antiviral agents were identified.•These agents could reinforce the arsenal of …
spectrum antiviral agents were identified.•These agents could reinforce the arsenal of …
Potential COVID‐19 therapeutic agents and vaccines: an evidence‐based review
Since the early days of 2020, the severe acute respiratory syndrome coronavirus 2
pandemic has become a global health concern. Currently, some therapies and vaccines …
pandemic has become a global health concern. Currently, some therapies and vaccines …
Therapeutic potential of salicylamide derivatives for combating viral infections
J Xu, Y Xue, AA Bolinger, J Li, M Zhou… - Medicinal Research …, 2023 - Wiley Online Library
Since time immemorial human beings have constantly been fighting against viral infections.
The ongoing and devastating coronavirus disease 2019 pandemic represents one of the …
The ongoing and devastating coronavirus disease 2019 pandemic represents one of the …
[HTML][HTML] Niclosamide inhibits hepatitis E virus through suppression of NF-kappaB signalling
Y Li, P Li, Q He, R Zhang, Y Li, N Kamar… - Antiviral Research, 2022 - Elsevier
Hepatitis E virus (HEV) infection can cause severe acute hepatitis in pregnant women and
chronic infection in immunocompromised patients, promoting the development of effective …
chronic infection in immunocompromised patients, promoting the development of effective …